These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21157375)

  • 1. Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.
    Damme M; Stroobants S; Walkley SU; Lüllmann-Rauch R; D'Hooge R; Fogh J; Saftig P; Lübke T; Blanz J
    J Neuropathol Exp Neurol; 2011 Jan; 70(1):83-94. PubMed ID: 21157375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term enzyme replacement therapy improves neurocognitive functioning and hippocampal synaptic plasticity in immune-tolerant alpha-mannosidosis mice.
    Stroobants S; Damme M; Van der Jeugd A; Vermaercke B; Andersson C; Fogh J; Saftig P; Blanz J; D'Hooge R
    Neurobiol Dis; 2017 Oct; 106():255-268. PubMed ID: 28720484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal alpha-mannosidase and alpha-mannosidosis.
    Paciotti S; Codini M; Tasegian A; Ceccarini MR; Cataldi S; Arcuri C; Fioretti B; Albi E; Beccari T
    Front Biosci (Landmark Ed); 2017 Jan; 22(1):157-167. PubMed ID: 27814608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired lysosomal trimming of N-linked oligosaccharides leads to hyperglycosylation of native lysosomal proteins in mice with alpha-mannosidosis.
    Damme M; Morelle W; Schmidt B; Andersson C; Fogh J; Michalski JC; Lübke T
    Mol Cell Biol; 2010 Jan; 30(1):273-83. PubMed ID: 19884343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis.
    Harmatz P; Cattaneo F; Ardigò D; Geraci S; Hennermann JB; Guffon N; Lund A; Hendriksz CJ; Borgwardt L
    Mol Genet Metab; 2018 Jun; 124(2):152-160. PubMed ID: 29716835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study.
    Borgwardt L; Dali CI; Fogh J; Månsson JE; Olsen KJ; Beck HC; Nielsen KG; Nielsen LH; Olsen SO; Riise Stensland HM; Nilssen O; Wibrand F; Thuesen AM; Pearl T; Haugsted U; Saftig P; Blanz J; Jones SA; Tylki-Szymanska A; Guffon-Fouiloux N; Beck M; Lund AM
    J Inherit Metab Dis; 2013 Nov; 36(6):1015-24. PubMed ID: 23494656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy in alpha-mannosidosis guinea-pigs.
    Crawley AC; King B; Berg T; Meikle PJ; Hopwood JJ
    Mol Genet Metab; 2006; 89(1-2):48-57. PubMed ID: 16807033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted disruption of the lysosomal alpha-mannosidase gene results in mice resembling a mild form of human alpha-mannosidosis.
    Stinchi S; Lüllmann-Rauch R; Hartmann D; Coenen R; Beccari T; Orlacchio A; von Figura K; Saftig P
    Hum Mol Genet; 1999 Aug; 8(8):1365-72. PubMed ID: 10400983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-Mannosidosis: Therapeutic Strategies.
    Ceccarini MR; Codini M; Conte C; Patria F; Cataldi S; Bertelli M; Albi E; Beccari T
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural characterisation of the alpha-mannosidosis guinea pig.
    Robinson AJ; Crawley AC; Auclair D; Weston PF; Hirte C; Hemsley KM; Hopwood JJ
    Behav Brain Res; 2008 Jan; 186(2):176-84. PubMed ID: 17889945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis.
    D'Hooge R; Lüllmann-Rauch R; Beckers T; Balschun D; Schwake M; Reiss K; von Figura K; Saftig P
    J Neurosci; 2005 Jul; 25(28):6539-49. PubMed ID: 16014715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study.
    Roces DP; Lüllmann-Rauch R; Peng J; Balducci C; Andersson C; Tollersrud O; Fogh J; Orlacchio A; Beccari T; Saftig P; von Figura K
    Hum Mol Genet; 2004 Sep; 13(18):1979-88. PubMed ID: 15269179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of alpha-Mannosidosis: Practical approaches to reducing diagnostic delays in this ultra-rare disease.
    Santoro L; Cefalo G; Canalini F; Rossi S; Scarpa M
    Mol Genet Metab; 2024 May; 142(1):108444. PubMed ID: 38555683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice.
    Blanz J; Stroobants S; Lüllmann-Rauch R; Morelle W; Lüdemann M; D'Hooge R; Reuterwall H; Michalski JC; Fogh J; Andersson C; Saftig P
    Hum Mol Genet; 2008 Nov; 17(22):3437-45. PubMed ID: 18713755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental analysis of CNS pathology in the lysosomal storage disease alpha-mannosidosis.
    Crawley AC; Walkley SU
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):687-97. PubMed ID: 17882013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-mannosidosis in the guinea pig: a new animal model for lysosomal storage disorders.
    Crawley AC; Jones MZ; Bonning LE; Finnie JW; Hopwood JJ
    Pediatr Res; 1999 Nov; 46(5):501-9. PubMed ID: 10541310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SPARKLE registry: protocol for an international prospective cohort study in patients with alpha-mannosidosis.
    Hennermann JB; Guffon N; Cattaneo F; Ceravolo F; Borgwardt L; Lund AM; Gil-Campos M; Tylki-Szymanska A; Muschol NM
    Orphanet J Rare Dis; 2020 Sep; 15(1):271. PubMed ID: 32993743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-mannosidosis - a review of genetic, clinical findings and options of treatment.
    Borgwardt L; Lund AM; Dali CI
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():185-91. PubMed ID: 25345101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Mannosidosis in the guinea pig: cloning of the lysosomal alpha-mannosidase cDNA and identification of a missense mutation causing alpha-mannosidosis.
    Berg T; Hopwood JJ
    Biochim Biophys Acta; 2002 Mar; 1586(2):169-76. PubMed ID: 11959458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of feline lysosomal alpha-mannosidase, determination of its cDNA sequence and identification of a mutation causing alpha-mannosidosis in Persian cats.
    Berg T; Tollersrud OK; Walkley SU; Siegel D; Nilssen O
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):863-70. PubMed ID: 9396732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.